Medication-Resistant Epilepsy Syndromes in Children

doi:10.1017/9781316492376.013

Chapter 13 - Medication-Resistant Epilepsy Syndromes in Children

Published online by Cambridge University Press: 20 August 2020

Elia M. Pestana Knight and

Edited by

Raman Sankar and

John M. Stern: Affiliation:
Geffen School of Medicine at UCLA, Los Angeles, CA
Raman Sankar: Affiliation:
Geffen School of Medicine at UCLA, Los Angeles, CA
Michael Sperling: Affiliation:
Jefferson Hospital for Neurosciences, Philadelphia, PA

Book contents

Get access

Summary

Medically refractory epilepsies account for 20–30% of the patients evaluated in an epilepsy centre. With more than 50% of paediatric epilepsies persisting into adulthood, it is very important for the epileptologist to have an updated understanding of the current advances in the field of medically refractory paediatric epileptic syndromes.

Refractory epilepsies are common in children. Medical intractability becomes quickly apparent after seizure onset in children with developmental epileptic encephalopathies [1].

Type: Chapter
Information: Medication-Resistant Epilepsy
Diagnosis and Treatment
, pp. 118 - 157

DOI: https://doi.org/10.1017/9781316492376.013 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Berg, AT, Vickrey, BG, Testa, FM, et al. How long does it take for epilepsy to become intractable?: a prospective investigation. Ann Neurol 2006;60(1):73–79CrossRef Google Scholar PubMed

Ohtahara, S, Yamatogi, Y. Ohtahara syndrome: with special reference to its developmental aspects for differentiating from early myoclonic encephalopathy. Epilepsy Res 2006;70(Suppl 1):S58–S67Google Scholar

Pavone, P, Spalice, A, Polizzi, A, Parisi, P, Ruggieri, M. Ohtahara syndrome with emphasis on recent genetic discovery. Brain Dev 2012;34(6):459–468CrossRef Google Scholar PubMed

Nieh, SE, Sherr, EH. Epileptic encephalopathies: new genes and new pathways. Neurotherapeutics 2014;11(4):796–806Google Scholar

Van Karnebeek, CD, Tiebout, SA, Niermeijer, J, et al. Pyridoxine-dependent epilepsy: an expanding clinical spectrum. Pediatr Neurol 2016;59:6–12CrossRef Google Scholar PubMed

Chien, YH, Lin, MI, Weng, WC, Du, JC, Lee, WT. Dextromethorphan in the treatment of early myoclonic encephalopathy evolving into migrating partial seizures in infancy. J Formos Med Assoc 2012;111(5):290–294CrossRef Google Scholar PubMed

Djukic, A, Lado, FA, Shinnar, S, Moshe, SL. Are early myoclonic encephalopathy (EME) and the Ohtahara syndrome (EIEE) independent of each other? Epilepsy Res 2006;70(Suppl 1):S68–S76CrossRef Google Scholar PubMed

Allen, NM, Mannion, M, Conroy, J, et al. The variable phenotypes of KCNQ-related epilepsy. Epilepsia 2014;55(9):e99–105Google Scholar

Maljevic, S, Lerche, H. Potassium channel genes and benign familial neonatal epilepsy. Prog Brain Res 2014;213:17–53CrossRef Google Scholar PubMed

Orhan, G, Bock, M, Schepers, D, et al. Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy. Ann Neurol 2014;75(3):382–394CrossRef Google Scholar PubMed

Millichap, JJ, Park, KL, Tsuchida, T, et al. KCNQ2 encephalopathy: features, mutational hot spots, and ezogabine treatment of 11 patients. Neurol Genet 2016;2(5):e96CrossRef Google Scholar PubMed

Numis, AL, Angriman, M, Sullivan, JE, et al. KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response. Neurology 2014;82(4):368–370Google Scholar

Pisano, T, Numis, AL, Heavin, SB, et al. Early and effective treatment of KCNQ2 encephalopathy. Epilepsia 2015;56(5):685–691CrossRef Google Scholar PubMed

Pan, Z, Kao, T, Horvath, Z, et al. A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon. J Neurosci 2006;26(10):2599–2613Google Scholar

Cowan, LD, Hudson, LS. The epidemiology and natural history of infantile spasms. J Child Neurol 1991;6(4):355–364CrossRef Google Scholar PubMed

Riikonen, R, Donner, M. Incidence and aetiology of infantile spasms from 1960 to 1976: a population study in Finland. Dev Med Child Neurol 1979;21(3):333–343CrossRef Google Scholar PubMed

Sidenvall, R, Eeg-Olofsson, O. Epidemiology of infantile spasms in Sweden. Epilepsia 1995;36(6):572–574CrossRef Google Scholar PubMed

Gaily, E, Lommi, M, Lapatto, R, Lehesjoki, AE. Incidence and outcome of epilepsy syndromes with onset in the first year of life: a retrospective population-based study. Epilepsia 2016;57(10):1594–1601Google Scholar

Cone, TE, Jr. On a peculiar form of infantile convulsions (hypsarrhythmia) as described in his own infant son by Dr W.J. West in 1841. Pediatrics 1970;46(4):603Google Scholar

Gibbs, EL, Fleming, MM, Gibbs, FA. Diagnosis and prognosis of hypsarhythmia and infantile spasms. Pediatrics 1954;13(1):66–73Google Scholar

Cerullo, A, Marini, C, Carcangiu, R, Baruzzi, A, Tinuper, P. Clinical and video-polygraphic features of epileptic spasms in adults with cortical migration disorder. Epileptic Disord 1999;1(1):27–33Google Scholar PubMed

Watanabe, K, Negoro, T, Okumura, A. Symptomatology of infantile spasms. Brain Dev 2001;23(7):453–466CrossRef Google Scholar PubMed

Lortie, A, Plouin, P, Chiron, C, Delalande, O, Dulac, O. Characteristics of epilepsy in focal cortical dysplasia in infancy. Epilepsy Res 2002;51(1–2):133–145Google Scholar

Donat, JF, Wright, FS. Simultaneous infantile spasms and partial seizures. J Child Neurol 1991;6(3):246–250Google Scholar

Donat, JF, Wright, FS. Unusual variants of infantile spasms. J Child Neurol 1991;6(4):313–318Google Scholar

Hrachovy, RA, Frost, JD, Jr, Kellaway, P. Hypsarrhythmia: variations on the theme. Epilepsia 1984;25(3):317–325Google Scholar

Caraballo, RH, Ruggieri, V, Gonzalez, G, et al. Infantile spams without hypsarrhythmia: a study of 16 cases. Seizure 2011;20(3):197–202CrossRef Google Scholar

Hussain, SA, Kwong, G, Millichap, JJ, et al. Hypsarrhythmia assessment exhibits poor interrater reliability: a threat to clinical trial validity. Epilepsia 2015;56(1):77–81Google Scholar

Fusco, L, Vigevano, F. Ictal clinical electroencephalographic findings of spasms in West syndrome. Epilepsia 1993;34(4):671–678CrossRef Google Scholar PubMed

Wilmshurst, JM, Gaillard, WD, Vinayan, KP, et al. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics. Epilepsia 2015;56(8):1185–1197CrossRef Google Scholar PubMed

Wirrell, EC, Shellhaas, RA, Joshi, C, et al. How should children with West syndrome be efficiently and accurately investigated?: results from the National Infantile Spasms Consortium. Epilepsia 2015;56(4):617–625Google Scholar

Mercimek-Mahmutoglu, S, Patel, J, Cordeiro, D, et al. Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. Epilepsia 2015;56(5):707–716Google Scholar

Helbig, KL, Farwell Hagman, KD, Shinde, DN, et al. Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy. Genet Med 2016;18(9):898–905Google Scholar

Mackay, MT, Weiss, SK, Adams-Webber, T, et al. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004;62(10):1668–1681CrossRef Google Scholar PubMed

Knupp, KG, Coryell, J, Nickels, KC, et al. Response to treatment in a prospective national infantile spasms cohort. Ann Neurol 2016;79(3):475–484CrossRef Google Scholar

Riikonen, RS. Favourable prognostic factors with infantile spasms. Eur J Paediatr Neurol 2010;14(1):13–18Google Scholar

Camfield, P, Camfield, C. Long-term prognosis for symptomatic (secondarily) generalized epilepsies: a population-based study. Epilepsia 2007;48(6):1128–1132Google Scholar

Riikonen, R. Long-term outcome of West syndrome: a study of adults with a history of infantile spasms. Epilepsia 1996;37(4):367–372Google Scholar

Riikonen, R. Long-term outcome of patients with West syndrome. Brain Dev 2001;23(7):683–687CrossRef Google Scholar PubMed

Coppola, G, Plouin, P, Chiron, C, Robain, O, Dulac, O. Migrating partial seizures in infancy: a malignant disorder with developmental arrest. Epilepsia 1995;36(10):1017–1024Google Scholar

McTague, A, Appleton, R, Avula, S, et al. Migrating partial seizures of infancy: expansion of the electroclinical, radiological and pathological disease spectrum. Brain 2013;136(Pt 5):1578–1591Google Scholar

Coppola, G. Malignant migrating partial seizures in infancy: an epilepsy syndrome of unknown etiology. Epilepsia 2009;50(Suppl 5):49–51Google Scholar

Freilich, ER, Jones, JM, Gaillard, WD, et al. Novel SCN1A mutation in a proband with malignant migrating partial seizures of infancy. Arch Neurol 2011;68(5):665–671Google Scholar

Poduri, A, Chopra, SS, Neilan, EG, et al. Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy. Epilepsia 2012;53(8):e146–e150Google Scholar

Milh, M, Falace, A, Villeneuve, N, et al. Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy. Hum Mutat 2013;34(6):869–872Google Scholar

Poduri, A, Heinzen, EL, Chitsazzadeh, V, et al. SLC25A22 is a novel gene for migrating partial seizures in infancy. Ann Neurol 2013;74(6):873–882CrossRef Google Scholar PubMed

Dhamija, R, Wirrell, E, Falcao, G, Kirmani, S, Wong-Kisiel, LC. Novel de novo SCN2A mutation in a child with migrating focal seizures of infancy. Pediatr Neurol 2013;49(6):486–488CrossRef Google Scholar

Barcia, G, Fleming, MR, Deligniere, A, et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet 2012;44(11):1255–1259Google Scholar

Ohba, C, Kato, M, Takahashi, S, et al. Early onset epileptic encephalopathy caused by de novo SCN8A mutations. Epilepsia 2014;55(7):994–1000CrossRef Google Scholar PubMed

Coppola, G, Veggiotti, P, Del Giudice, EM, et al. Mutational scanning of potassium, sodium and chloride ion channels in malignant migrating partial seizures in infancy. Brain Dev 2006;28(2):76–79CrossRef Google Scholar PubMed

Lim, BC, Hwang, H, Kim, H, et al. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: migrating partial seizures of infancy or atypical Dravet syndrome? Epilepsy Res 2015;109:34–39Google Scholar

Iyer, RS, Thanikasalam, , Krishnan, M. Migrating partial seizures in infancy and 47XYY syndrome: cause or coincidence? Epilepsy Behav Case Rep 2014;2:43–45CrossRef Google Scholar PubMed

De Filippo, MR, Rizzo, F, Marchese, G, et al. Lack of pathogenic mutations in six patients with MMPSI. Epilepsy Res 2014;108(2):340–344Google Scholar

Merdariu, D, Delanoe, C, Mahfoufi, N, Bellavoine, V, Auvin, S. Malignant migrating partial seizures of infancy controlled by stiripentol and clonazepam. Brain Dev 2013;35(2):177–180CrossRef Google Scholar PubMed

Djuric, M, Kravljanac, R, Kovacevic, G, Martic, J. The efficacy of bromides, stiripentol and levetiracetam in two patients with malignant migrating partial seizures in infancy. Epileptic Disord 2011;13(1):22–26Google Scholar

Vendrame, M, Poduri, A, Loddenkemper, T, et al. Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases. Epileptic Disord 2011;13(1):18–21Google Scholar

Caraballo, R, Noli, D, Cachia, P. Epilepsy of infancy with migrating focal seizures: three patients treated with the ketogenic diet. Epileptic Disord 2015;17(2):194–197Google Scholar

Caraballo, RH, Valenzuela, GR, Armeno, M, et al. The ketogenic diet in two paediatric patients with refractory myoclonic status epilepticus. Epileptic Disord 2015;17(4):491–495Google Scholar

Cilio, MR, Bianchi, R, Balestri, M, et al. Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy. Epilepsy Res 2009;86(1):66–71CrossRef Google Scholar PubMed

Irahara, K, Saito, Y, Sugai, K, et al. Effects of acetazolamide on epileptic apnea in migrating partial seizures in infancy. Epilepsy Res 2011;96(1–2):185–189Google Scholar

Unver, O, Incecik, F, Dundar, H, et al. Potassium bromide for treatment of malignant migrating partial seizures in infancy. Pediatr Neurol 2013;49(5):355–357CrossRef Google Scholar PubMed

Saade, D, Joshi, C. Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report. Pediatr Neurol 2015;52(5):544–547Google Scholar

Bearden, D, Strong, A, Ehnot, J, et al. Targeted treatment of migrating partial seizures of infancy with quinidine. Ann Neurol 2014;76(3):457–461CrossRef Google Scholar PubMed

Mikati, MA, Jiang, YH, Carboni, M, et al. Quinidine in the treatment of KCNT1-positive epilepsies. Ann Neurol 2015;78(6):995–999Google Scholar

Bearden, D, DiGiovine, M, Dlugos, D, Goldberg, E. Reply. Ann Neurol 2016;79(3):503–504CrossRef Google Scholar PubMed

Engel, J, Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001;42(6):796–803Google Scholar

Fujiwara, T, Sugawara, T, Mazaki-Miyazaki, E, et al. Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic–clonic seizures. Brain 2003;126(Pt 3):531–546CrossRef Google Scholar PubMed

Berkovic, SF, Harkin, L, McMahon, JM, et al. De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study. Lancet Neurol 2006;5(6):488–492CrossRef Google Scholar PubMed

Jansen, FE, Sadleir, LG, Harkin, LA, et al. Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults. Neurology 2006;67(12):2224–2226CrossRef Google Scholar PubMed

Wolff, M, Casse-Perrot, C, Dravet, C. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia 2006;47(Suppl 2):45–48CrossRef Google Scholar PubMed

Scheffer, IE, Turner, SJ, Dibbens, LM, et al. Epilepsy and mental retardation limited to females: an under-recognized disorder. Brain 2008;131(Pt 4):918–927Google Scholar

Devinsky, O, Nabbout, R, Miller, I, et al. Long-term cannabidiol treatment in patients with Dravet syndrome: an open-label extension trial. Epilepsia 2019;60(2):294–302Google Scholar

Bialer, M, Johannessen, SI, Koepp, MJ, et al. Progress report on new antiepileptic drugs: a summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development. Epilepsia 2018;59(10):1811–1841CrossRef Google Scholar

Genton, P, Velizarova, R, Dravet, C. Dravet syndrome: the long-term outcome. Epilepsia 2011;52(Suppl 2):44–49Google Scholar

Akiyama, M, Kobayashi, K, Yoshinaga, H, Ohtsuka, Y. A long-term follow-up study of Dravet syndrome up to adulthood. Epilepsia 2010;51(6):1043–1052Google Scholar

Camfield, PR. Definition and natural history of Lennox-Gastaut syndrome. Epilepsia 2011;52(Suppl 5):3–9Google Scholar

Proposal for revised classification of epilepsies and epileptic syndromes: Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989;30(4):389–399Google Scholar

Scheffer, IE, Berkovic, S, Capovilla, G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017;58(4):512–521CrossRef Google Scholar PubMed

Cherian, A, Jabeen, SA, Kandadai, RM, et al. Epilepsy with myoclonic absences in siblings. Brain Dev 2014;36(10):892–898Google Scholar

Bureau, M, Tassinari, CA. Epilepsy with myoclonic absences. Brain Dev 2005;27(3):178–184CrossRef Google Scholar PubMed

Kalviainen, R. Progressive myoclonus epilepsies. Semin Neurol 2015;35(3):293–299Google Scholar PubMed

Vaca, GF, Lenz, T, Knight, EM, Tuxhorn, I. Gaucher disease: successful treatment of myoclonic status epilepticus with levetiracetam. Epileptic Disord 2012;14(2):155–158Google Scholar

Gastaut, H, Tassinari, CA. Triggering mechanisms in epilepsy: the electroclinical point of view. Epilepsia 1966;7(2):85–138CrossRef Google Scholar PubMed

Arzimanoglou, A, Resnick, T. All children who experience epileptic falls do not necessarily have Lennox-Gastaut syndrome … but many do. Epileptic Disord 2011;13(Suppl 1):S3–S13Google Scholar

Arzimanoglou, A, Resnick, T. Diagnosing and treating epileptic drop attacks, atypical absences and episodes of nonconvulsive status epilepticus. Epileptic Disord 2011;13(Suppl 1):S1-S2Google Scholar PubMed

Wyllie, E, Lachhwani, DK, Gupta, A, et al. Successful surgery for epilepsy due to early brain lesions despite generalized EEG findings. Neurology 2007;69(4):389–397CrossRef Google Scholar PubMed

Gupta, A, Chirla, A, Wyllie, E, et al. Pediatric epilepsy surgery in focal lesions and generalized electroencephalogram abnormalities. Pediatr Neurol 2007;37(1):8–15CrossRef Google Scholar PubMed

Carvill, GL, Heavin, SB, Yendle, SC, et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet 2013;45(7):825–830Google Scholar

Allen, AS, Berkovic, SF, Cossette, P, et al. De novo mutations in epileptic encephalopathies. Nature 2013;501(7466):217–221Google Scholar

Dravet, C, Natale, O, Magaudda, A, et al. [Status epilepticus in the Lennox-Gastaut syndrome]. Rev Electroencephalogr Neurophysiol Clin 1986;15(4):361–368Google Scholar

Sinclair, DB. Prednisone therapy in pediatric epilepsy. Pediatr Neurol 2003;28(3):194–198Google Scholar

Yamatogi, Y, Ohtsuka, Y, Ishida, T, et al. Treatment of the Lennox syndrome with ACTH: a clinical and electroencephalographic study. Brain Dev 1979;1(4):267–276Google Scholar

Bello-Espinosa, LE, Rajapakse, T, Rho, JM, Buchhalter, J. Efficacy of intravenous immunoglobulin in a cohort of children with drug-resistant epilepsy. Pediatr Neurol 2015;52(5):509–516CrossRef Google Scholar

Billiau, AD, Witters, P, Ceulemans, B, et al. Intravenous immunoglobulins in refractory childhood-onset epilepsy: effects on seizure frequency, EEG activity, and cerebrospinal fluid cytokine profile. Epilepsia 2007;48(9):1739–1749Google Scholar

Kossoff, EH, Krauss, GL, McGrogan, JR, Freeman, JM. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology 2003;61(12):1789–1791Google Scholar

Kossoff, EH, McGrogan, JR, Bluml, RM, et al. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 2006;47(2):421–424CrossRef Google Scholar PubMed

Sirven, J, Whedon, B, Caplan, D, et al. The ketogenic diet for intractable epilepsy in adults: preliminary results. Epilepsia 1999;40(12):1721–1726Google Scholar

Lancman, G, Virk, M, Shao, H, et al. Vagus nerve stimulation vs. corpus callosotomy in the treatment of Lennox-Gastaut syndrome: a meta-analysis. Seizure 2013;22(1):3–8CrossRef Google Scholar PubMed

Iwasaki, M, Uematsu, M, Nakayama, T, et al. Parental satisfaction and seizure outcome after corpus callosotomy in patients with infantile or early childhood onset epilepsy. Seizure 2013;22(4):303–305Google Scholar

Maehara, T, Shimizu, H. Surgical outcome of corpus callosotomy in patients with drop attacks. Epilepsia 2001;42(1):67–71Google Scholar

Park, MS, Nakagawa, E, Schoenberg, MR, Benbadis, SR, Vale, FL. Outcome of corpus callosotomy in adults. Epilepsy Behav 2013;28(2):181–184Google Scholar

Roger, J, Remy, C, Bureau, M, et al. [Lennox-Gastaut syndrome in the adult]. Rev Neurol (Paris) 1987;143(5):401–405Google Scholar

Boyer, JP, Deschatrette, A, Delwarde, M. [Convulsive autism?: apropos of 9 cases of primary autism associated with the Lennox-Gastaut syndrome]. Pediatrie 1981;36(5):353–368Google Scholar

Camfield, C, Camfield, P. Twenty years after childhood-onset symptomatic generalized epilepsy the social outcome is usually dependency or death: a population-based study. Dev Med Child Neurol 2008;50(11):859–863Google Scholar

Doose, H, Gerken, H, Leonhardt, R, Volzke, E, Volz, C. Centrencephalic myoclonic-astatic petit mal. Clinical and genetic investigation. Neuropadiatrie 1970;2(1):59–78CrossRef Google Scholar PubMed

Guerrini, R, Aicardi, J. Epileptic encephalopathies with myoclonic seizures in infants and children (severe myoclonic epilepsy and myoclonic-astatic epilepsy). J Clin Neurophysiol 2003;20(6):449–461Google Scholar

Harkin, LA, McMahon, JM, Iona, X, et al. The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain 2007;130(Pt 3):843–852Google Scholar

Kilaru, S, Bergqvist, AG. Current treatment of myoclonic astatic epilepsy: clinical experience at the Children’s Hospital of Philadelphia. Epilepsia 2007;48(9):1703–1707Google Scholar

Oguni, H, Tanaka, T, Hayashi, K, et al. Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood. Neuropediatrics 2002;33(3):122–132Google Scholar

Camfield, P, Camfield, C. Epileptic syndromes in childhood: clinical features, outcomes, and treatment. Epilepsia 2002;43(Suppl 3):27–32Google Scholar

Caraballo, RH, Cejas, N, Chamorro, N, et al. Landau-Kleffner syndrome: a study of 29 patients. Seizure 2014;23(2):98–104Google Scholar

Sánchez Fernández, I, Loddenkemper, T, Peters, JM, Kothare, SV. Electrical status epilepticus in sleep: clinical presentation and pathophysiology. Pediatr Neurol 2012;47(6):390–410Google Scholar

Fernandez, IS, Chapman, KE, Peters, JM, et al. The tower of Babel: survey on concepts and terminology in electrical status epilepticus in sleep and continuous spikes and waves during sleep in North America. Epilepsia 2013;54(4):741–750Google Scholar

Van Hirtum-Das, M, Licht, EA, Koh, S, et al. Children with ESES: variability in the syndrome. Epilepsy Res 2006;70(Suppl 1):S248–S258Google Scholar

Loddenkemper, T, Cosmo, G, Kotagal, P, et al. Epilepsy surgery in children with electrical status epilepticus in sleep. Neurosurgery 2009;64(2):328–337CrossRef Google Scholar PubMed

Sánchez Fernández, I, Chapman, KE, Peters, JM, et al. Continuous spikes and waves during sleep: electroclinical presentation and suggestions for management. Epilepsy Res Treat 2013;2013:583531Google Scholar

Turner, SJ, Morgan, AT, Perez, ER, Scheffer, IE. New genes for focal epilepsies with speech and language disorders. Curr Neurol Neurosci Rep 2015;15(6):35Google Scholar

Lal, D, Steinbrucker, S, Schubert, J, et al. Investigation of GRIN2A in common epilepsy phenotypes. Epilepsy Res 2015;115:95–99Google Scholar

Vigevano, F, Arzimanoglou, A, Plouin, P, Specchio, N. Therapeutic approach to epileptic encephalopathies. Epilepsia 2013;54(Suppl 8):45–50Google Scholar

Veggiotti, P, Pera, MC, Teutonico, F, et al. Therapy of encephalopathy with status epilepticus during sleep (ESES/CSWS syndrome): an update. Epileptic Disord 2012;14(1):1–11Google Scholar

Inutsuka, M, Kobayashi, K, Oka, M, Hattori, J, Ohtsuka, Y. Treatment of epilepsy with electrical status epilepticus during slow sleep and its related disorders. Brain Dev 2006;28(5):281–286Google Scholar

Mikati, MA, Shamseddine, AN. Management of Landau-Kleffner syndrome. Paediatr Drugs 2005;7(6):377–389Google Scholar

Okuyaz, C, Aydin, K, Gucuyener, K, Serdaroglu, A. Treatment of electrical status epilepticus during slow-wave sleep with high-dose corticosteroid. Pediatr Neurol 2005;32(1):64–67Google Scholar

Wilson, RB, Eliyan, Y, Sankar, R, Hussain, SA. Amantadine: a new treatment for refractory electrical status epilepticus in sleep. Epilepsy Behav 2018;84:74–78Google Scholar

Gross-Selbeck, G. Treatment of “benign” partial epilepsies of childhood, including atypical forms. Neuropediatrics 1995;26(1):45–50CrossRef Google Scholar PubMed

Raybarman, C. Landau-Kleffner syndrome: a case report. Neurol India 2002;50(2):212–213Google Scholar PubMed

Fainberg, N, Harper, A, Tchapyjnikov, D, Mikati, MA. Response to immunotherapy in a patient with Landau-Kleffner syndrome and GRIN2A mutation. Epileptic Disord 2016;18(1):97–100Google Scholar

Mikati, MA, Saab, R. Successful use of intravenous immunoglobulin as initial monotherapy in Landau-Kleffner syndrome. Epilepsia 2000;41(7):880–886CrossRef Google Scholar PubMed

Irwin, K, Birch, V, Lees, J, et al. Multiple subpial transection in Landau-Kleffner syndrome. Dev Med Child Neurol 2001;43(4):248–252Google Scholar

Pierson, TM, Yuan, H, Marsh, ED, et al. GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine. Ann Clin Transl Neurol 2014;1(3):190–198Google Scholar

Ben-Ari, Y, Holmes, GL. Effects of seizures on developmental processes in the immature brain. Lancet Neurol 2006;5(12):1055–1063Google Scholar

Holmes, GL, Lenck-Santini, PP. Role of interictal epileptiform abnormalities in cognitive impairment. Epilepsy Behav 2006;8(3):504–515CrossRef Google Scholar PubMed

Holmes, GL. Clinical evidence that epilepsy is a progressive disorder with special emphasis on epilepsy syndromes that do progress. Adv Neurol 2006;97:323–331Google Scholar

Shatskikh, TN, Raghavendra, M, Zhao, Q, Cui, Z, Holmes, GL. Electrical induction of spikes in the hippocampus impairs recognition capacity and spatial memory in rats. Epilepsy Behav 2006;9(4):549–556Google Scholar

Hernan, AE, Alexander, A, Lenck-Santini, PP, Scott, RC, Holmes, GL. Attention deficit associated with early life interictal spikes in a rat model is improved with ACTH. PLoS One 2014;9(2):e89812Google Scholar

Nordli, DR, Jr. Idiopathic generalized epilepsies recognized by the International League Against Epilepsy. Epilepsia 2005;46(Suppl 9):48–56Google Scholar

Janz, D. Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy). Acta Neurol Scand 1985;72(5):449–459Google Scholar

Wirrell, EC, Camfield, CS, Camfield, PR, Gordon, KE, Dooley, JM. Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy. Neurology 1996;47(4):912–918Google Scholar

Panayiotopoulos, CP. Idiopathic generalized epilepsies: a review and modern approach. Epilepsia 2005;46(Suppl 9):1–6Google Scholar

Camfield, CS, Camfield, PR. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology 2009;73(13):1041–1045CrossRef Google Scholar PubMed

Glauser, T, Ben-Menachem, E, Bourgeois, B, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2013;54(3):551–563Google Scholar

Camfield, C, Camfield, P. Management guidelines for children with idiopathic generalized epilepsy. Epilepsia 2005;46(Suppl 9):112–116Google Scholar

Baykan, B, Altindag, EA, Bebek, N, et al. Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy. Neurology 2008;70(22 Pt 2): 2123–2129Google Scholar

Striano, S, Capovilla, G, Sofia, V, et al. Eyelid myoclonia with absences (Jeavons syndrome): a well-defined idiopathic generalized epilepsy syndrome or a spectrum of photosensitive conditions? Epilepsia 2009;50(Suppl 5):15–19Google Scholar

Engel, J, Jr. Report of the ILAE classification core group. Epilepsia 2006;47(9):1558–1568Google Scholar

Jeavons, PM. Nosological problems of myoclonic epilepsies in childhood and adolescence. Dev Med Child Neurol 1977;19(1):3–8Google Scholar

Yang, ZX, Cai, X, Liu, XY, Qin, J. Relationship among eye condition sensitivities, photosensitivity and epileptic syndromes. Chin Med J (Engl) 2008;121(17):1633–1637Google Scholar

Striano, S, Striano, P, Nocerino, C, et al. Eyelid myoclonia with absences: an overlooked epileptic syndrome? Neurophysiol Clin 2002;32(5):287–296CrossRef Google Scholar PubMed

Adachi, N, Kanemoto, K, Muramatsu, R, et al. Intellectual prognosis of status epilepticus in adult epilepsy patients: analysis with Wechsler Adult Intelligence Scale-revised. Epilepsia 2005;46(9):1502–1509Google Scholar

Viravan, S, Go, C, Ochi, A, et al. Jeavons syndrome existing as occipital cortex initiating generalized epilepsy. Epilepsia 2011;52(7):1273–1279Google Scholar

Striano, P, Sofia, V, Capovilla, G, et al. A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome). Epilepsia 2008;49(3):425–430CrossRef Google Scholar PubMed

Jung, DE, Yu, R, Yoon, JR, et al. Neuropsychological effects of levetiracetam and carbamazepine in children with focal epilepsy. Neurology 2015;84(23):2312–2319Google Scholar

Molokwu, OA, Ezeala-Adikaibe, BA, Onwuekwe, IO. Levetiracetam-induced rage and suicidality: two case reports and review of literature. Epilepsy Behav Case Rep 2015;4:79–81Google Scholar

Menon, R, Baheti, NN, Cherian, A, Iyer, RS. Oxcarbazepine induced worsening of seizures in Jeavons syndrome: lessons learnt from an interesting presentation. Neurol India 2011;59(1):70–72Google Scholar

Capovilla, G, Gambardella, A, Rubboli, G, et al. Suppressive efficacy by a commercially available blue lens on PPR in 610 photosensitive epilepsy patients. Epilepsia 2006;47(3):529–533Google Scholar

Cross, JH, Jayakar, P, Nordli, D, et al. Proposed criteria for referral and evaluation of children for epilepsy surgery: recommendations of the Subcommission for Pediatric Epilepsy Surgery. Epilepsia 2006;47(6):952–959Google Scholar

Pestana Knight, EM, Schiltz, NK, Bakaki, PM, et al. In response: epilepsy surgery trends in the U.S. – differences between kids and adults. Epilepsia 2015;56(8):1321–1322Google Scholar

Pestana Knight, EM, Schiltz, NK, Bakaki, PM, et al. Increasing utilization of pediatric epilepsy surgery in the United States between 1997 and 2009. Epilepsia 2015;56(3):375–381Google Scholar

Dunkley, C, Kung, J, Scott, RC, et al. Epilepsy surgery in children under 3 years. Epilepsy Res 2011;93(2–3):96–106CrossRef Google Scholar PubMed

Gowda, S, Salazar, F, Bingaman, WE, et al. Surgery for catastrophic epilepsy in infants 6 months of age and younger. J Neurosurg Pediatr 2010;5(6):603–607Google Scholar

Wyllie, E, Comair, YG, Kotagal, P, Raja, S, Ruggieri, P. Epilepsy surgery in infants. Epilepsia 1996;37(7):625–637Google Scholar

Wyllie, E, Comair, Y, Ruggieri, P, Raja, S, Prayson, R. Epilepsy surgery in the setting of periventricular leukomalacia and focal cortical dysplasia. Neurology 1996;46(3):839–841Google Scholar

Wyllie, E. Surgery for catastrophic localization-related epilepsy in infants. Epilepsia 1996;37(Suppl 1):S22–S25Google Scholar

Chugani, HT, Shields, WD, Shewmon, DA, et al. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol 1990;27(4):406–413Google Scholar

Moosa, AN, Jehi, L, Marashly, A, et al. Long-term functional outcomes and their predictors after hemispherectomy in 115 children. Epilepsia 2013;54(10):1771–1779Google Scholar

Lee, YJ, Kang, HC, Lee, JS, et al. Resective pediatric epilepsy surgery in Lennox–Gastaut syndrome. Pediatrics 2010;125(1):e58–e66Google Scholar

Lee, YJ, Lee, JS, Kang, HC, et al. Outcomes of epilepsy surgery in childhood-onset epileptic encephalopathy. Brain Dev 2014;36(6):496–504Google Scholar

Moosa, AN, Gupta, A, Jehi, L, et al. Longitudinal seizure outcome and prognostic predictors after hemispherectomy in 170 children. Neurology 2013;80(3):253–260Google Scholar

Van den Munckhof, B, van D, V, Sagi, L, et al. Treatment of electrical status epilepticus in sleep: a pooled analysis of 575 cases. Epilepsia 2015;56(11):1738–1746Google Scholar

Sillanpaa, M, Jalava, M, Kaleva, O, Shinnar, S. Long-term prognosis of seizures with onset in childhood. N Engl J Med 1998;338(24):1715–1722Google Scholar

Looman, WS, Lindeke, LL. Children and youth with special health care needs: partnering with families for effective advocacy. J Pediatr Health Care 2008;22(2):134–136Google Scholar

Camfield, PR, Gibson, PA, Douglass, LM. Strategies for transitioning to adult care for youth with Lennox–Gastaut syndrome and related disorders. Epilepsia 2011;52(Suppl 5):21–27Google Scholar

Blum, RW. Introduction: improving transition for adolescents with special health care needs from pediatric to adult-centered health care. Pediatrics 2002; 110(6 Pt 2):1301–1303Google Scholar

Kelly, AM, Kratz, B, Bielski, M, Rinehart, PM. Implementing transitions for youth with complex chronic conditions using the medical home model. Pediatrics 2002;110(6 Pt 2):1322–1327Google Scholar

Book contents

Chapter 13 - Medication-Resistant Epilepsy Syndromes in Children

Summary

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive